Log in

Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings

  • First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy
  • Hepatoma, Radioiodinated Fatty Acid Ester, Interventional Radiology, Hepatocellular Carcinoma
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Radioiodinated fatty acid esters, such as lipiodol or ethiodol, are localized in the hypervascular hepatocellular carcinoma (HCC) for a long time following intra-arterial hepatic injection, enabling delivery of high internal radiation to the tumor. The desired radiation can easily be delivered to small HCC, less than 5 cm in diameter, in single or multiple procedures with an 8-week interval. For larger tumors, [131I]lipiodol or [131I]ethiodol in conjunction with chemotherapy emulsion, Ivalon embolization or all three combinations should be considered for maximal clinical results. A strong beta emitter with shorter physical half-life, i.e.90Y will be more effective in the management of HCC if one can label lipiodol with90Y.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bookstein J (1985) Hepatocellular carcinoma: recent advances in diagnosis with iodized oil 54: 253

    Google Scholar 

  2. Iwai K, Kooni T, Maeda H (1980) Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image 44: 2115

    Google Scholar 

  3. Konno K, Maeda H, Iwai K, et al. (1983) Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lumphographic agent on hepatoma: a preliminary report 19: 1053

    Google Scholar 

  4. Madson MT, Park CH, Thakur ML, et al. (1987) A dosimetric comparison of I-131, Y-90 and P-32 as radiolabels for ethiodol in the treatment of hepatoma. Presented at american Association of Physicists in Medicine. 29th Annual Meeting, Detroit, Michigan, July 19–23, 1987

  5. Nakakuma K, Tashiro S, Hiraoka T et al. (1985) Hepatocellular carcinoma and metastic cancer detected by iodized oil. Radiology 154, 15

    Google Scholar 

  6. Ohishi H, Uchida H, Yoshimura H, et al. (1985) Hepatocellular carcinoma detected by iodized oil: use of anticancer agents. Radiology 154: 25

    Google Scholar 

  7. Ohnish K, Tsuchya S, Nakayma T, et al. (1984) Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules. Radiology 152: 51

    Google Scholar 

  8. Park CH, Suh JH, Yoo HS, et al. (1986) Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma-therapeutic feasibility. Clin Nucl Med 11: 514

    Google Scholar 

  9. Satoh M, Yamada R (1983) Experimental and clinical studies on the hepatic artery embolization for treatment of hepatoma. Nippon Acta Radiol 43: 977 (In Japanese)

    Google Scholar 

  10. Yoo HS, Suh JH, Lee JT, et al. (1986) Therapeutic trial of intrahepatic I-131-lipiodol on patients with hepatocellular carcinoma. Korean J, Gastroenterol 18: 217

    Google Scholar 

  11. Yoo HS, Suh JH, Lee JT, et al. (1986) Therapeutic feasibility study and clinical trial of I-131-lipiodol on patients with hepatocellular carcinoma. Korean Nucl Med 20: 61

    Google Scholar 

  12. Yumoto Y, **nok, Tokuyma K, et al. (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154: 19

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by Yonsei Cancer Center Research Grant

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoo, H.S., Park, C.H., Suh, J.H. et al. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings. Cancer Chemother. Pharmacol. 23 (Suppl 1), S54–S58 (1989). https://doi.org/10.1007/BF00647241

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00647241

Keywords

Navigation